Singapore markets closed

Cyclerion Therapeutics, Inc. (CYCN)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
2.9300-0.2100 (-6.69%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
297
3,320
2,296
Operating expenses
Research development
1,515
1,515
5,979
37,636
56,414
Selling general and administrative
8,132
8,132
12,858
20,620
28,816
Total operating expenses
9,647
9,647
18,837
57,634
85,230
Operating income or loss
-9,647
-9,647
-18,540
-54,314
-82,934
Interest expense
-
-
-
16
-
Total other income/expenses net
-3,304
-3,304
-
2,683
4,544
Income before tax
-12,593
-12,593
-18,246
-51,647
-77,802
Income from continuing operations
-12,593
-12,593
-18,246
-51,647
-77,802
Net income
-5,263
-5,263
-44,078
-51,647
-77,802
Net income available to common shareholders
-5,263
-5,263
-44,078
-51,647
-77,802
Basic EPS
-4.79
-
-20.28
-26.40
-51.20
Diluted EPS
-4.79
-
-20.28
-26.40
-51.20
Basic average shares
2,268
-
2,173
1,957
1,520
Diluted average shares
2,268
-
2,173
1,957
1,520